| |
|
|
Il Sung Pharm. Co.,Ltd. (003120) |
|
|
STOCK |
|
|
|
  |
(unit : Won, Share) |
| Fiscal Year End |
06.12 | 07.12 | 08.12 | 09.09 |
| Par Value |
5,000 | 5,000 | 5,000 | 5,000 |
| Yearly Highest Price |
85,900 | 141,000 | 118,500 | 71,800 |
| Yearly Lowest Price |
48,000 | 77,700 | 43,950 | 54,100 |
| Common Shares O/S |
2,660,000 | 2,660,000 | 2,660,000 | 2,660,000 |
| Preferred Shares O/S |
- | - | - | - |
| Market Cap.(100Mn.Won) |
2,258 | 2,992 | 1,915 | 1,723 |
| Dividends (%) |
10.0 | 10.0 | 10.0 | - |
|
 |
(Company/Sector/Market) |
| |
2008.06 | 2009.06 |
| Beta |
0.58 / 0.68 / 1.00 | 0.59 / 0.54 / 1.00 |
| Volatility |
39.53 / 23.43 / 26.01 | 53.87 / 32.47 / 41.28 |
|
 |
(unit : Won) |
| Fiscal Year End |
06.12 | 07.12 | 08.12 | 09.09 |
| Earnings Per Share |
14,485 | 6,700 | 14,046 | 3,498 |
| Sales Per Share |
29,545 | 29,841 | 32,837 | 36,029 |
| Book Value Per Share |
86,563 | 150,375 | 92,645 | 113,560 |
| Cash Flow Per Share |
4,470.45 | 1,579.05 | 6,798.51 | 2,136.76 |
|
 |
(Unit : Times) |
| Fiscal Year End |
06.12 | 07.12 | 08.12 | 09.09 |
| Price / Earnings (H/L) |
5.93/3.31 | 21.04/11.60 | 8.44/3.13 | 20.52/15.46 |
| Price / Sales (H/L) |
2.91/1.62 | 4.72/2.60 | 3.61/1.34 | 1.99/1.50 |
| Price / Book (H/L) |
0.99/0.55 | 0.94/0.52 | 1.28/0.47 | 0.63/0.48 |
| Price / Cash Flow (H/L) |
19.22 / 10.74 | 89.29 / 49.21 | 17.43 / 6.46 | 33.60 / 25.32 |
|
 |
(Unit : 100Mn.Won, %) |
| Fiscal Year End |
05.12 |
06.12 |
07.12 |
08.12 |
| Company |
Sector |
Company |
Sector |
Company |
Sector |
Company |
Sector |
| Invested Capital |
450 |
731 |
524 |
714 |
572 |
708 |
592 |
942 |
| NOPLAT |
142 |
70 |
151 |
54 |
145 |
60 |
121 |
71 |
| Return on Invested Capital |
31 |
9 |
28 |
7 |
25 |
8 |
20 |
7 |
| WACC |
6 |
6 |
5 |
6 |
6 |
6 |
6 |
6 |
| Economic Value Added |
110.8 |
22.1 |
121.0 |
8.6 |
110.0 |
10.9 |
81.6 |
5.3 |
|
 |
(Unit : 100Mn.Won, Times) |
| Fiscal Year End |
2006.12 | 2007.12 | 2008.12 | 2009.09 |
| Enterprise Value(EV) |
2,258.34 | 2,992.50 | 1,915.20 | 1,723.68 |
| EBITDA |
228.56 | 219.46 | 220.82 | 148.15 |
| EBITDA/Sales |
0.29 | 0.28 | 0.28 | 0.21 |
| EBITDA/Financial Exp. |
622.13 | 659.92 | 69.56 | 79.32 |
| EV/EBITDA |
9.88 | 13.64 | 8.67 | 11.63 |
|
|
|
|
